載入...
A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels
The primary goal of precision medicine is to maximize the benefit‐risk relationships for individual patients by delivering the right drug to the right patients at the right dose. To achieve this goal, it has become increasingly important to assess gene‐drug interactions (GDIs) in clinical settings....
Na minha lista:
| 發表在: | Clin Transl Sci |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301579/ https://ncbi.nlm.nih.gov/pubmed/33742770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.13000 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|